Structure-neurotoxicity trends of analogues of 1-methyl-4-phenylpyridinium (MPP+), the cytotoxic metabolite of the dopaminergic neurotoxin MPTP
- 1 January 1990
- journal article
- research article
- Published by Elsevier in Life Sciences
- Vol. 46 (5), 379-390
- https://doi.org/10.1016/0024-3205(90)90018-m
Abstract
No abstract availableThis publication has 45 references indexed in Scilit:
- Biochemical mechanism of action of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)Toxicology Letters, 1989
- MPTP Toxicity: Implications for Research in Parkinson's DiseaseAnnual Review of Neuroscience, 1988
- Biochemistry of the neurotoxic action of MPTP: or how a faulty batch of ‘designer drug’ led to parkinsonism in drug abusersTrends in Biochemical Sciences, 1987
- Model study on the bioreduction of paraquat, MPP+, and analogs. Evidence against a “redox cycling” mechanism in MPTP neurotoxicityBiochemical and Biophysical Research Communications, 1987
- E/Z-equilibria. 11. Structure of a metalated Schiff baseJournal of the American Chemical Society, 1986
- MPTPNeurology, 1986
- Metabolism of the neurotoxin in MPTP by human liver monoamine oxidase BFEBS Letters, 1985
- Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridineLife Sciences, 1985
- MPTP and parkinson's diseaseTrends in Neurosciences, 1985
- Superoxide-and Ethane-Formation in Subchloroplast Particles: Catalysis by Pyridinium DerivativesZeitschrift für Naturforschung C, 1980